Jason Drummond

1.5k total citations
7 papers, 225 citations indexed

About

Jason Drummond is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Jason Drummond has authored 7 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Jason Drummond's work include Synthesis and biological activity (2 papers), Cancer Mechanisms and Therapy (2 papers) and Plant Gene Expression Analysis (2 papers). Jason Drummond is often cited by papers focused on Synthesis and biological activity (2 papers), Cancer Mechanisms and Therapy (2 papers) and Plant Gene Expression Analysis (2 papers). Jason Drummond collaborates with scholars based in United Kingdom, China and Spain. Jason Drummond's co-authors include Jeremy Murray, Vickie Tsui, John G. Moffat, Anthony A. Estrada, Allen Ebens, Haitao Zhu, Grace Chan, Huifen Chen, Tracy Kleinheinz and Heidi J.A. Wallweber and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Peptides.

In The Last Decade

Jason Drummond

7 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Drummond United Kingdom 6 136 78 46 43 39 7 225
Eric Stefan United States 9 78 0.6× 100 1.3× 33 0.7× 17 0.4× 35 0.9× 9 193
Lionel Muller Switzerland 8 158 1.2× 98 1.3× 115 2.5× 21 0.5× 20 0.5× 11 341
Tania Tahtouh France 5 225 1.7× 105 1.3× 29 0.6× 16 0.4× 8 0.2× 8 383
Dingwei Yu United States 9 120 0.9× 46 0.6× 46 1.0× 11 0.3× 8 0.2× 12 273
Natalie T. Rundle Canada 6 260 1.9× 30 0.4× 66 1.4× 24 0.6× 8 0.2× 6 339
Snahel Patel United States 9 187 1.4× 86 1.1× 46 1.0× 5 0.1× 8 0.2× 10 325
Erica C. VanderPorten United States 9 178 1.3× 30 0.4× 67 1.5× 31 0.7× 4 0.1× 9 282
Qingyan Au United States 9 143 1.1× 18 0.2× 43 0.9× 8 0.2× 13 0.3× 23 230
L Jaszlits Hungary 5 263 1.9× 28 0.4× 44 1.0× 16 0.4× 24 0.6× 15 354
Omar Moukha‐Chafiq United States 11 203 1.5× 133 1.7× 15 0.3× 45 1.0× 4 0.1× 35 390

Countries citing papers authored by Jason Drummond

Since Specialization
Citations

This map shows the geographic impact of Jason Drummond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Drummond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Drummond more than expected).

Fields of papers citing papers by Jason Drummond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Drummond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Drummond. The network helps show where Jason Drummond may publish in the future.

Co-authorship network of co-authors of Jason Drummond

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Drummond. A scholar is included among the top collaborators of Jason Drummond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Drummond. Jason Drummond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Shore, Daniel G., Zachary K. Sweeney, Alan Beresford, et al.. (2018). Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2. Bioorganic & Medicinal Chemistry Letters. 29(4). 674–680. 8 indexed citations
2.
Martin, Leenus, Tzuling Cheng, Dominic I. James, et al.. (2018). Abstract 1943: PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition. Cancer Research. 78(13_Supplement). 1943–1943. 4 indexed citations
3.
Lello, Paola Di, Richard Pastor, Jeremy Murray, et al.. (2017). Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques. Journal of Medicinal Chemistry. 60(24). 10056–10070. 65 indexed citations
4.
Wang, Xiaojing, Aleksandr Kolesnikov, Suzanne Tay, et al.. (2017). Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability. Journal of Medicinal Chemistry. 60(10). 4458–4473. 19 indexed citations
5.
Wang, Xiaojing, Steven Magnuson, Huiyong Hu, et al.. (2013). Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Bioorganic & Medicinal Chemistry Letters. 23(11). 3149–3153. 55 indexed citations
6.
Chen, Huifen, Bryan Chan, Jason Drummond, et al.. (2012). Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling. Journal of Medicinal Chemistry. 55(11). 5536–5545. 60 indexed citations
7.
Fuente, Mónica De la, et al.. (1996). Modulation of murine peritoneal macrophage functions by gastrin. Peptides. 17(2). 219–224. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026